Category
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Today's News
More News
Pembrolizumab Monotherapy Displays Efficacy in Rare Sarcomas

Pembrolizumab Monotherapy Displays Efficacy in Rare Sarcomas

The PD-1 inhibitor pembrolizumab (Keytruda) displayed activity with a manageable safety profile in patients with certain rare and ultra-raresarcoma histotypes, according to findings from the phase 2 A

Pembrolizumab Monotherapy Displays Efficacy in Rare Sarcomas

The PD-1 inhibitor pembrolizumab (Keytruda) displayed activity with a manageable safety profile in patients with certain rare and ultra-raresarcoma histotypes, according to findings from the phase 2 A
Single-cell proteomics – when mass spectrometry revolutionizes biomedical research

Single-cell proteomics – when mass spectrometry revolutionizes biomedical research

insightsfrom industryNikolai SlavovFounding DirectorParallel Squared Technology InstituteIn the latest episode of the OMG Omx podcast, Bruker's Kate Stumpo talks to Nikolai Slavov about the

Single-cell proteomics – when mass spectrometry revolutionizes biomedical research

insightsfrom industryNikolai SlavovFounding DirectorParallel Squared Technology InstituteIn the latest episode of the OMG Omx podcast, Bruker's Kate Stumpo talks to Nikolai Slavov about the
Immuno-Oncology Approaches Continue to Advance Across Gynecologic Cancers

Immuno-Oncology Approaches Continue to Advance Across Gynecologic Cancers

Single-agent and/or combination immunotherapy approaches continue to reign supreme in the treatment of patients with endometrial cancer. Several recent trials have reinforced their role in the first a

Immuno-Oncology Approaches Continue to Advance Across Gynecologic Cancers

Single-agent and/or combination immunotherapy approaches continue to reign supreme in the treatment of patients with endometrial cancer. Several recent trials have reinforced their role in the first a
Medicaid plays critical role in the health and wellbeing of adults with Down syndrome

Medicaid plays critical role in the health and wellbeing of adults with Down syndrome

Life expectancy has increased substantially for people in the United States with Down syndrome, from a median age of 4 years old in the 1950s to 57 years old in 2019. This longer life span increases t

Medicaid plays critical role in the health and wellbeing of adults with Down syndrome

Life expectancy has increased substantially for people in the United States with Down syndrome, from a median age of 4 years old in the 1950s to 57 years old in 2019. This longer life span increases t
Bioengineered tissue from stem cells could help patients recover from damaging heart attacks

Bioengineered tissue from stem cells could help patients recover from damaging heart attacks

A new technology that uses bio-printed "patches" to repair damaged heart tissue has been proven to be safer and more cost-effective for patients than other patches.Researchers from The Unive

Bioengineered tissue from stem cells could help patients recover from damaging heart attacks

A new technology that uses bio-printed "patches" to repair damaged heart tissue has been proven to be safer and more cost-effective for patients than other patches.Researchers from The Unive
Medicare expands the roster of available mental health professionals

Medicare expands the roster of available mental health professionals

Lynn Cooper was going through an awful time. After losing her job in 2019, she became deeply depressed. Then the covid-19 pandemic hit, and her anxiety went through the roof. Then her cherished therap

Medicare expands the roster of available mental health professionals

Lynn Cooper was going through an awful time. After losing her job in 2019, she became deeply depressed. Then the covid-19 pandemic hit, and her anxiety went through the roof. Then her cherished therap
Medical-legal partnerships can help improve maternal and infant health outcomes

Medical-legal partnerships can help improve maternal and infant health outcomes

Medical-legal partnerships (MLPs), which include a lawyer as part of a patient's care team, can help health systems address health-harming legal needs and better support pregnant and postpartum pa

Medical-legal partnerships can help improve maternal and infant health outcomes

Medical-legal partnerships (MLPs), which include a lawyer as part of a patient's care team, can help health systems address health-harming legal needs and better support pregnant and postpartum pa
Chemotherapy plus immunotherapy improves survival in patients with metastatic urothelial cancer

Chemotherapy plus immunotherapy improves survival in patients with metastatic urothelial cancer

A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients with an advanced type of bladder cancer. Th

Chemotherapy plus immunotherapy improves survival in patients with metastatic urothelial cancer

A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients with an advanced type of bladder cancer. Th
Speeding up Alzheimer's research: Progerin turbocharges cellular models for quicker drug screening

Speeding up Alzheimer's research: Progerin turbocharges cellular models for quicker drug screening

The pathogenesis of Alzheimer’s Disease (AD), a leading cause of dementia, remains unclear. One notable limitation of current cellular models is that they lack an agingin vitroenvironment.

Speeding up Alzheimer's research: Progerin turbocharges cellular models for quicker drug screening

The pathogenesis of Alzheimer’s Disease (AD), a leading cause of dementia, remains unclear. One notable limitation of current cellular models is that they lack an agingin vitroenvironment.
Scientists call for regulation of stem cell 'treatment' fads

Scientists call for regulation of stem cell 'treatment' fads

Scientists are calling for tighter regulation of stem cell treatments, after finding hundreds of clinics worldwide offering unproven "therapies" for conditions as varied as hair loss and Par

Scientists call for regulation of stem cell 'treatment' fads

Scientists are calling for tighter regulation of stem cell treatments, after finding hundreds of clinics worldwide offering unproven "therapies" for conditions as varied as hair loss and Par
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...